title: Circulating haemopoietic and endothelial progenitor cells are decreased in COPD.
abstract: Circulating CD34+ cells are haemopoietic progenitors that may play a role in tissue repair. No data are available on circulating progenitors in chronic obstructive pulmonary disease (COPD). Circulating CD34+ cells were studied in 18 patients with moderate-to-severe COPD (age: mean+/-sd 68+/-8 yrs; forced expiratory volume in one second: 48+/-12% predicted) and 12 controls, at rest and after endurance exercise. Plasma concentrations of haematopoietic growth factors (FMS-like tyrosine kinase 3 (Flt3) ligand, kit ligand), markers of hypoxia (vascular endothelial growth factor (VEGF)) and stimulators of angiogenesis (VEGF, hepatocyte growth factor (HGF)) and markers of systemic inflammation (tumour necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-8) were measured. Compared with the controls, the COPD patients showed a three-fold reduction in CD34+ cell counts (3.3+/-2.5 versus 10.3+/-4.2 cells.microL-1), and a 50% decrease in AC133+ cells. In the COPD patients, progenitor-derived haemopoietic and endothelial cell colonies were reduced by 30-50%. However, four COPD patients showed progenitor counts in the normal range associated with lower TNF-alpha levels. In the entire sample, CD34+ cell counts correlated with exercise capacity and severity of airflow obstruction. After endurance exercise, progenitor counts were unchanged, while plasma Flt3 ligand and VEGF only increased in the COPD patients. Plasma HGF levels were higher in the COPD patients compared with the controls and correlated inversely with the number of progenitor-derived colonies. In conclusion, circulating CD34+ cells and endothelial progenitors were decreased in chronic obstructive pulmonary disease patients and could be correlated with disease severity.
authors.affiliation: Dipartimento di Medicina Clinica, University La Sapienza, Viale Università 37, Rome, 00185 Italy. paolo.palange@uniroma1.it
authors.forename: P
authors.initials: P
authors.lastname: Palange
authors.forename: U
authors.initials: U
authors.lastname: Testa
authors.forename: A
authors.initials: A
authors.lastname: Huertas
authors.forename: L
authors.initials: L
authors.lastname: Calabrò
authors.forename: R
authors.initials: R
authors.lastname: Antonucci
authors.forename: E
authors.initials: E
authors.lastname: Petrucci
authors.forename: E
authors.initials: E
authors.lastname: Pelosi
authors.forename: L
authors.initials: L
authors.lastname: Pasquini
authors.forename: A
authors.initials: A
authors.lastname: Satta
authors.forename: G
authors.initials: G
authors.lastname: Morici
authors.forename: M A
authors.initials: MA
authors.lastname: Vignola
authors.forename: M R
authors.initials: MR
authors.lastname: Bonsignore
mesh_terms: D000368:Aged; D018952:Antigens, CD34; D002452:Cell Count; D042783:Endothelial Cells / Q000276:immunology; D006412:Hematopoietic Stem Cells / Q000276:immunology; D006801:Humans; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood*; D013234:Stem Cells / Q000276:immunology
chemical_list: D018952:Antigens, CD34